Search research articles
Contact Us
Filters
Showing results (81-90 of 193) with videos related to
Page
of 20
Sort By:
Current Oncology (Toronto, Ont.)
|
January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
British Journal of Haematology
|
May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology
|
January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience
Mattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
Hematological Oncology
|
September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
British Journal of Haematology
|
July 27, 2020
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia
Andrea Corbingi, Idanna Innocenti, Annamaria Tomasso, et al.
Plos One
|
March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
Francesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
Blood
|
November 12, 2020
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment
Laura Patrussi, Noemi Manganaro, Nagaja Capitani, et al.
BMC Medicine
|
June 30, 2026
Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia
Maria Castronuovo, Guido Capasso, Allison Beltrame, et al.
British Journal of Haematology
|
July 6, 2018
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
Andrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, et al.
International Journal of Cancer
|
May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
Federica Frezzato, Flavia Raggi, Veronica Martini, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 193) with videos related to
Sort By:
Page
of 20
Current Oncology (Toronto, Ont.)
|
January 20, 2023
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
British Journal of Haematology
|
May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Frontiers in Oncology
|
January 29, 2026
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience
Mattia D'Antiga, Andrea Serafin, Francesco Angotzi, et al.
Hematological Oncology
|
September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
British Journal of Haematology
|
July 27, 2020
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia
Andrea Corbingi, Idanna Innocenti, Annamaria Tomasso, et al.
Plos One
|
March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
Francesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
Blood
|
November 12, 2020
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment
Laura Patrussi, Noemi Manganaro, Nagaja Capitani, et al.
BMC Medicine
|
June 30, 2026
Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia
Maria Castronuovo, Guido Capasso, Allison Beltrame, et al.
British Journal of Haematology
|
July 6, 2018
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
Andrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, et al.
International Journal of Cancer
|
May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
Federica Frezzato, Flavia Raggi, Veronica Martini, et al.
Page
of 20